Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Integrated Diagnostics Holdings ( (GB:IDHC) ) has issued an announcement.
Integrated Diagnostics Holdings (IDH) announced that it will release its unaudited financial results for the first quarter of 2025 on May 28, 2025. The company will also host an analyst and investor call on June 2, 2025, to discuss these results. This announcement highlights IDH’s continued commitment to transparency and engagement with its stakeholders, reinforcing its position as a leading diagnostics services provider in its operational regions.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings (IDH) is a prominent diagnostics services provider in the Middle East and Africa, offering a wide array of clinical pathology and radiology tests. Operating in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan, the company is recognized for its quality and safety standards, with over 40 years of experience and a portfolio of more than 3,000 diagnostic tests. IDH operates 628 branches, serving over 8.9 million patients and conducting more than 39.2 million tests in 2024. The company aims to expand through a Hub, Spoke, and Spike business model and seeks growth in the Middle Eastern, African, and East Asian markets.
Average Trading Volume: 370,143
Technical Sentiment Signal: Strong Sell
Current Market Cap: $209.3M
See more data about IDHC stock on TipRanks’ Stock Analysis page.